Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BMY
Recent news which mentions BMY
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Is Bristol Myers Squibb Stock a Buy?
Today 8:00 EST
Tickers
BMY
Tags
Recent Press Releases
Market News
BMY
From
Motley Fool
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
Today 4:33 EST
Tickers
BMY
ENB
KHC
Tags
Recent Press Releases
KHC
Market News
From
Motley Fool
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
November 18, 2024
Tickers
BMY
NEWS
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
November 15, 2024
Tickers
BMY
NEWS
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
November 15, 2024
Tickers
AMGN
BLK
BMY
CSCO
Tags
Recent Press Releases
AMGN
BMY
From
Motley Fool
2 Beaten-Down Dividend Stocks to Buy and Hold
November 14, 2024
Tickers
BMY
CVS
Tags
Recent Press Releases
Market News
CVS
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
Tickers
ALT
AMGN
BMY
BSX
Tags
Benzinga
Market News
ALT
From
Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
November 13, 2024
Tickers
BMY
NEWS
SYRS
Tags
Biotech
Trading Ideas
Benzinga
From
Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
NBIX
General
Briefs
From
Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
Tickers
ARGX
BMY
IFF
IHRT
Tags
ARGX
S
IHRT
From
Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
November 12, 2024
Tickers
ABBV
BMY
LLY
NEWS
Tags
LLY
Health Care
ABBV
From
Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
November 11, 2024
Tickers
ABBV
BMY
NEWS
Tags
Market News
Movers
ABBV
From
Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
November 11, 2024
Tickers
ABBV
BMY
NEWS
Tags
Reiteration
Trading Ideas
Health Care
From
Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
November 11, 2024
Tickers
BMY
EVO
NEWS
NVO
Tags
EVO
Media
Rumors
From
Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
November 11, 2024
Tickers
ABBV
BMY
NEWS
Tags
General
Benzinga
Stories That Matter
From
Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
November 11, 2024
Tickers
AFRM
BMY
BTBT
BTDR
Tags
Markets
BTBT
Market News
From
Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
Tickers
ABBV
ALNY
BMY
GILD
Tags
GILD
Market News
BMY
From
Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
November 06, 2024
Tickers
BMY
NEWS
NVO
TEVA
Tags
General
Briefs
Biotech
From
Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
Tickers
BMY
MRK
NEWS
SMMT
Tags
Briefs
Price Target
Expert Ideas
From
Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
November 04, 2024
Tickers
BMY
Tags
Benzinga
Trading Ideas
Short Ideas
From
Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
November 01, 2024
Tickers
BMY
NEWS
Tags
General
Expert Ideas
Briefs
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
Pro Project
Tech
AMGN
From
Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
October 31, 2024
Tickers
BMY
Tags
BMY
Recent Press Releases
Market News
From
Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
October 31, 2024
Tickers
BMY
NEWS
Tags
Movers
Biotech
Benzinga
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
Expert Ideas
Stories That Matter
Large Cap
From
Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Tickers
BMY
GILD
LYEL
NEWS
Tags
Stories That Matter
Benzinga
Biotech
From
Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
October 23, 2024
Tickers
BMY
Tags
Market News
Markets
BMY
From
Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
October 23, 2024
Tickers
BMY
IBRX
MRK
NEWS
Tags
General
Stories That Matter
Benzinga
From
Benzinga
Why Is Evotec Stock Gaining Today?
October 23, 2024
Tickers
BMY
EVO
NEWS
Tags
Briefs
Stories That Matter
Benzinga
From
Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
October 17, 2024
Tickers
ALMS
BMY
NEWS
TAK
Tags
News
Trading Ideas
Health Care
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.